WOBURN, MA -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the pricing of its initial public offering of 3,060,000 shares of its common stock and accompanying warrants to purchase up [...]

The two companies will work with the Environmental Molecular Science Laboratory, a U.S. Department of Energy user facility located at PNNL, and will leverage Cellenion’s flagship platform for single cell isolation and nanoliter dispensing Today, SCIENION and Cellenion, drivers of BICO, a leading bio convergence company, announced that they have exclusively licensed a PNNL invention and have also [...]

New Spatial Proteomics Pilot Program provides streamlined path to high-definition spatial analysis of the tissue microenvironment   MENLO PARK, Calif. — Ionpath, Inc., the leader in high-definition spatial proteomics, today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company’s Multiplexed Ion Beam Imaging (MIBI™) [...]

York, UK and Uppsala, Sweden – Aptamer Group Ltd, the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, the developer and manufacturer of leading-edge agarose-based purification technologies, today announce that they have entered into an agreement to co-develop a new affinity resin for improved purification and [...]

Spatial omics firm appoints new VP Scientific Affairs and two Principal Scientists SANTA CLARA, CA – Rebus Biosystems, Inc., (“Rebus Bio”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced Tarif Awad, a highly experienced technical and commercial leader within the world of life sciences, has joined Rebus Bio as VP [...]

BOSTON, Mass. -- TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers. As part of an Andelyn Biosciences initiative to create a Connected Plant that harmonizes data from building and facilities, process and manufacturing, [...]

Merck KGaA, Darmstadt, Germany, today announced that Dirk Toepfer, Group Chief Information Officer (CIO) and Head of Information Technology, has decided to leave Merck effective August 31. Darmstadt, Germany – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that Dirk Toepfer, Group Chief Information Officer (CIO) and Head of Information Technology, [...]

Markham, Ontario – Alpha Controls & Instrumentation is pleased to announce the addition of validation to their current service offering.  With over 40 years of instrumentation experience, Alpha Controls is a company you can trust as your compliance partner. Marc Brand, Director of Sales & Service for Alpha Controls shares, “At Alpha Controls & Instrumentation we strive [...]

BIRMINGHAM, Ala. -- TriAltus Bioscience announced that the U.S Patent and Trademark Office has issued U.S. Patent No 10,759,830 for its CLīM affinity tag system, which delivers proteins with ultra-high purity and yield in a single step. The patent, entitled "Bacterial colicin-immunity protein purification system," covers mutations made to colicin E7, a naturally occurring e.coli protein, [...]

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif. -- The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be candidates for Servier Pharmaceuticals' [...]